Ipilimumab/nivolumab

Severe radiation necrosis, hepatitis and colitis: 3 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Shi DD, et al. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy. World Neurosurgery 139: 226-231, Jul 2020. Available from: URL: http://doi.org/10.1016/j.wneu.2020.04.087

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ipilimumab/nivolumab. Reactions Weekly 1809, 138 (2020). https://doi.org/10.1007/s40278-020-79922-4

    Download citation